175137-14-1

Basic information

• Product Name: 1-PHENYL-5-(TRIFLUOROMETHYL)PYRAZOLE-4-CARBONYL CHLORIDE
• Synonyms: 1-PHENYL-5-(TRIFLUOROMETHYL)PYRAZOLE-4-CARBONYL CHLORIDE;1-PHENYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBONYL CHLORIDE;1-Phenyl-5-(trifluoromethyl)pyrazole-4-carbonyl chloride 97%;1-Phenyl-5-(trifluoromethyl)pyrazole-4-carbonylchloride97%;1-Phenyl-5-(trifluoromethyl)pyrazole-4-carbonyl;1-Phenyl-5-(trifluoromethyl)-1H-pyrazole-4-carbonyl chloride 97%;1-Phenyl-5-(trifluoromethyl)-1H-pyrazole-4-carbonylchloride97%;TIMTEC-BB SBB001093
• CAS NO: 175137-14-1
• Molecular Formula: C₁₁H₆ClF₃N₂O
• Molecular Weight: 274.63
• Mol File: 175137-14-1.mol

Chemical Properties

• Melting Point: 40 °C
• Boiling Point: 110 °C
• Flash Point: 175.3°C
• Appearance: /
• Density: 1.55g/cm³
• Vapor Pressure: 8.13E-05mmHg at 25°C
• Refractive Index: 1.556
• CAS DataBase Reference: 1-PHENYL-5-(TRIFLUOROMETHYL)PYRAZOLE-4-CARBONYL CHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-PHENYL-5-(TRIFLUOROMETHYL)PYRAZOLE-4-CARBONYL CHLORIDE(175137-14-1)
• EPA Substance Registry System: 1-PHENYL-5-(TRIFLUOROMETHYL)PYRAZOLE-4-CARBONYL CHLORIDE(175137-14-1)

Safety Data

• Hazard Codes: Xi,C
• Statements: 34
• Safety Statements: 26-36/37/39
• RIDADR: 3265
• HazardClass: CORROSIVE
• Hazardous Substances Data: 175137-14-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-Phenyl-5-(trifluoromethyl)pyrazole-4-carbonyl chloride is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to participate in multiple chemical reactions, making it a valuable component in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, 1-Phenyl-5-(trifluoromethyl)pyrazole-4-carbonyl chloride is used as a building block in the creation of agrochemical products. Its reactivity and stability contribute to the formulation of effective pesticides and other agricultural chemicals.
Used in Dye Industry:
1-Phenyl-5-(trifluoromethyl)pyrazole-4-carbonyl chloride is employed as a key intermediate in the production of dyes. Its chemical properties enable the creation of a wide range of colorants used in various applications, such as textiles, plastics, and printing inks.

InChI:InChI=1/C11H6ClF3N2O/c12-10(18)8-6-16-17(9(8)11(13,14)15)7-4-2-1-3-5-7/h1-6H

Upstream product

• 571-55-1 ethyl 2-(ethoxymethylidene)-4,4,4-trifluoro-3-oxobutanoate 
• 112055-34-2 ethyl 1-phenyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate 
• 100-63-0 phenylhydrazine 
• 98534-81-7 1-phenyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid 

Downstream Products

• 848853-21-4 methyl ({4'-[({[1-phenyl-5-(trifluoromethyl)-1H-pyrazol-4-yl]carbonyl}amino)methyl][1,1'-biphenyl]-4-yl}oxy)acetate 
• 1125886-02-3 C₁₆H₁₁F₃N₄O 
• 1265322-68-6 (S)-1-((S)-2-hydroxy-2-(4-(5-(1-phenyl-5-(trifluoromethyl)-1H-pyrazol-4-yl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)piperidine-3-carboxylic acid 

Relevant articles and documents

Synthesis, Biological Evaluation, and 3D-QSAR Studies of N-(Substituted pyridine-4-yl)-1-(substituted phenyl)-5-trifluoromethyl-1 H-pyrazole-4-carboxamide Derivatives as Potential Succinate Dehydrogenase Inhibitors

A series of new fungicides that can inhibit the succinate dehydrogenase (SDH) was classified and named as SDH inhibitors by the Fungicide Resistance Action Committee in 2009. To develop more potential SDH inhibitors, we designed and synthesized a novel se

Aromatic imide compounds and preparation method and application thereof

The invention discloses aromatic imide derivatives with the chemical structure shown as the general formula (I) and a preparation method and anticancer activity thereof. R1 and R2 are defined in the specification. Part of the compounds have good anticance

SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS

Disclosed are compounds of Formula (I), or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein: A is formula (II) Q is a substituted 5-membered monocyclic heteroaryl group; W is CH2, O, or NH; and R1, R2, R3, R4, R5, R6, m, n, t, and x are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.